Charles River Laboratories Acquires WIL Research from Happi

29 January 2016

Gains access to additional capabilities and markets.

Charles River recently announced plans to acquire WIL Research, a premier provider of safety assessment and contract development and manufacturing services to biopharmaceutical, agricultural and industrial chemical companies worldwide.

Additionally, in the fourth quarter of 2015, Oncotest, a Germany-based contract research organization providing discovery services for oncology, became part of the Charles River portfolio.

According to Charles River, these acquisitions deliver additional scientific capabilities and access to global markets to better serve its customers.



Save time and find easily the methods and the testing suppliers to substantiate your Cosmetics & Personal Care claims.

Don't miss our weekly newsletter

* Receive regular news of what's moving the world of preclinical and clinical testing of the Beauty industry

Save time and easily find the methods and test providers to validate your product claims.